About Careers MedBlog Contact us

FDA Considers Approval of New Anti Tuberculosis Drug

by Colleen Fleiss on August 11, 2019 at 7:26 PM
Font : A-A+

FDA Considers Approval of New Anti Tuberculosis Drug

CD8+ T cells help control infection and aid in the development of an improved tuberculosis (TB) vaccine, revealed Dr. Lewinsohn's research interest is in Tuberculosis Immunology.

Dr. Lewinsohn is a professor of Pulmonary and Critical Care Medicine, vice chair for research in the Department of Medicine, and is director of the OHSU Center for Global Child Health Research, Department of Pediatrics at Oregon Health & Sciences University. He also holds adjunct appointments in Molecular Microbiology & Immunology as well as the Vaccine and Gene Therapy Institute.


This work has resulted in the creation of a small OHSU startup, ViTi, that he manages with Deborah Lewinsohn. ViTi was created to take the work in the lab, and to develop improved diagnostics for TB. Dr. Lewinsohn has collaborated with the CDC, the TB Research Unit (TBRU), the Kwazulu-Natal Research Institute for HIV and TB, the South African TB Vaccine Initiative, the AERAS Global Vaccine Foundation, Oxford University and UCSF. Dr. Lewinsohn was the co-chair of the ATS/CDC/IDSA committee to develop new guidelines for the diagnosis of infection with Mtb.

Dr. Lewinsohn's research has been supported by the ALA, the NIH, the Aeras Global Vaccine Foundation, the Bill and Melinda Gates Foundation and the VA. Dr. Lewinsohn has worked closely with the StopTB Partnership, is currently the chair of the Vaccines Working group, has represented the New Tools working groups for the past three years on the BOD, and is on the executive committee.

Source: Newswise


Recommended Reading

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

FDA Considers Approval of New Anti Tuberculosis Drug Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests